Eastman Chemical Company (EMN) SEC Filings & Earnings Calls
EquiReason read 11 Eastman Chemical Company SEC filings in the last 12 months. Latest: 8-K on 2026-10-20 — Eastman Chemical amended its bylaws to align with Delaware law, update procedural mechanics for stockholder meetings and nominations, and make ministerial changes. No material fina.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
- Market cap
- 7.4B
- P/E TTM
- 16.9
- Dividend yield
- 5.2%
- 52-week
- —
- Next earnings
- 29 Oct, in 5 days
Every filing, read
last 12 months · SECWhat happened, the numbers inside, guidance and risks. The original is one click away.
31 Jul 202610-QEastman Chemical reported Q2 2026 revenue up 10% YoY and EBIT ex non-core up 16%, driven by pricing and volume/mix.earningsopen
Figures in the filing · each found in the filing text
| Sales · Q2-2026 | $2.51B | +10% y/y |
| Gross profit · Q2-2026 | $560M | +11% y/y |
| EBIT excluding non-core items · Q2-2026 | $320M | +16% y/y |
| Net earnings attributable to Eastman · Q2-2026 | $183M | +31% y/y |
| Adjusted net earnings attributable to Eastman · Q2-2026 | $227M | +22% y/y |
| Cash provided by operating activities · H1-2026 | $87M | +32% y/y |
Risks flagged
Raw material and energy cost inflation
“EBIT excluding non-core items decreased in first six months 2026 compared to first six months 2025 primarily due to ... higher raw material and energy costs.” · word for word
Middle East conflict supply disruption
“Higher selling prices in the CI segment were primarily driven by tightening market conditions from the ongoing Middle East conflict.” · word for word
30 Jul 20268-K · 2.02Sales revenue $2.51B (+10% y/y); Adjusted EBIT $320M (+16% y/y); Adjusted earnings per diluted share $1.97 (+23% y/y); Guidance: Expect modest tailwind from price increases in back half; cost savings $125-150Mearningsopen
Figures in the filing · each found in the filing text
| Sales revenue · Q2-2026 | $2.51B | +10% y/y |
| Adjusted EBIT · Q2-2026 | $320M | +16% y/y |
| Adjusted earnings per diluted share · Q2-2026 | $1.97 | +23% y/y |
| Net cash provided by operating activities · Q2-2026 | $224M | -4% y/y |
Guidance
Expect modest tailwind from price increases in back half; cost savings $125-150M
Management reaffirms full-year 2026 outlook with cautious optimism; expects modest growth in stable end markets and tailwind from price increases.
Risks flagged
Middle East conflict impacts raw material supply and logistics costs.
“Continued to successfully manage the impact of the conflict in the Middle East and secured supply of key raw materials.” · word for word
Weak demand in discretionary end markets and Fibers segment.
“Continued weak demand in key discretionary end markets... Fibers sales revenue decreased 11 percent.” · word for word
1 May 202610-QSales $2.18B (-5% y/y); Gross profit $431M (-24% y/y); EBIT $188M (-38% y/y)open
Figures in the filing · each found in the filing text
| Sales · Q1-2026 | $2.18B | -5% y/y |
| Gross profit · Q1-2026 | $431M | -24% y/y |
| EBIT · Q1-2026 | $188M | -38% y/y |
| Net earnings attributable to Eastman · Q1-2026 | $107M | -41% y/y |
| Adjusted net earnings attributable to Eastman · Q1-2026 | $125M | -44% y/y |
| Diluted EPS · Q1-2026 | $0.93 | -41% y/y |
| Adjusted diluted EPS · Q1-2026 | $1.09 | -43% y/y |
| Operating cash flow · Q1-2026 | $-137M | +18% y/y |
Risks flagged
Demand weakness across consumer discretionary end markets
“Lower sale volume was primarily driven by customer inventory destocking in the acetate tow product line as well as continued weakness across consumer discretionary end markets.” · word for word
Commodity market weakness in Chemical Intermediates segment
“Lower selling prices were due to lower raw material prices and continued weak commodity market conditions in the CI segment.” · word for word
Energy cost pressure from weather events
“EBIT excluding non-core items decreased ... due to ... increased energy costs across our businesses resulting from Winter Storm Fern.”
30 Apr 20268-K · 2.02Sales revenue $2.18B (-5% y/y); Adjusted EBIT $200M (-36% y/y); Adjusted earnings per diluted share $1.09 (-43% y/y)earningsopen
Figures in the filing · each found in the filing text
| Sales revenue · Q1-2026 | $2.18B | -5% y/y |
| Adjusted EBIT · Q1-2026 | $200M | -36% y/y |
| Adjusted earnings per diluted share · Q1-2026 | $1.09 | -43% y/y |
| Net cash used in operating activities · Q1-2026 | $-137M | +18% y/y |
Risks flagged
Significant earnings decline with revenue down 5% and adjusted EBIT down 36% YoY; customer destocking in acetate tow and weak consumer discretionary demand are key risks.
“Sales revenue decreased 5 percent; Adjusted EBIT decreased 36% to $200M; Fibers sales revenue decreased 22% due to 19% lower sales volume/mix.”
Raw material and distribution inflation requiring ~$500M price increases; energy costs from Winter Storm Fern added pressure.
“Implementing ~$500 million of price increases across the portfolio to offset substantial raw material and distribution inflation; increased energy costs across our businesses resulting from Winter Storm Fern.” · word for word
24 Mar 2026DEF 14AProxy statement disclosing executive compensation structure, pay-for-performance alignment, and incentive plan design for 2025.open
Figures in the filing · each found in the filing text
| Revenue · FY2025 | $8.75B | |
| EBIT · FY2025 | $776M | |
| Adjusted EBIT · FY2025 | $930M | |
| EPS · FY2025 | $4.10 | |
| Adjusted EPS · FY2025 | $5.42 | |
| Operating Cash Flow · FY2025 | $970M | |
| Net Income · FY2025 | $475M | |
| Free Cash Flow Returned to Shareholders · FY2025 | $500M | |
| CEO Target Total Direct Compensation · FY2025 | $14M | |
| CEO Realized Compensation · FY2025 | $987000.00 |
Risks flagged
Tariff and trade disruption risk
“The adjusted EBIT target was set at $1.20 billion, which was slightly below the 2024 actual adjusted EBIT of $1.298 billion in response to continued industry weakness and anticipated impacts from global tariffs and trade disruption.” · word for word
Industry weakness and cyclical demand risk
“Despite a challenging operating environment in 2025, our team demonstrated the resilience of our portfolio and the strength of our cash generation.” · word for word
Stock price decline and equity award underwater risk
“The year-end share price was $63.83; the grant date share price of the PSAs was $101.28; the grant date share price of the RSUs was $100.56; and the exercise price of the stock options was $100.56.” · word for word
Strategic goal underperformance risk
“For the 2023-2025 PSAs, the Committee approved an overall PSA payout for the NEOs at 75% of target award levels... (ii) a 5% reduction in the PSA payout based on the performance against the strategic corporate goals under the Modifier.” · word for word
20 Feb 20268-K · 1.01, 8.01Eastman Chemical Company issued notes via underwriting agreement, expecting net proceeds of ~$593.7M for general corporate purposes, including capex and debt repayment.open
Risks flagged
Increased leverage from new debt issuance
“Issuance of $593.7M in notes increases debt obligations”
13 Feb 202610-KSales Revenue $8.80B; EBIT $776M; Net Earnings Attributable to Eastman $474Mopen
Figures in the filing · each found in the filing text
| Sales Revenue · FY2025 | $8.80B | |
| EBIT · FY2025 | $776M | |
| Net Earnings Attributable to Eastman · FY2025 | $474M | |
| Diluted Earnings Per Share · FY2025 | $4.10 | |
| Net Cash Provided by Operating Activities · FY2025 | $970M | |
| Adjusted EBIT · FY2025 | $930M | |
| Adjusted Diluted EPS · FY2025 | $5.42 | |
| Molecular Recycling Facility Output Growth · Advanced Materials · FY2025 | $2.50 | +150% y/y |
Risks flagged
Raw Material and Energy Cost Volatility
“The cost of raw materials and energy is generally based on market price at the time of purchase” · word for word
Cyclicality in Chemical Intermediates
“Several CI segment product lines are affected by cyclicality, most notably olefin and acetyl-based products.” · word for word
Geopolitical and Trade Disruption
“impacts from U.S. tariffs, reciprocal tariffs, and global trade disruption” · word for word
29 Jan 20268-K · 2.02Sales revenue $1.97B (-12% y/y); EBIT $64M (-82% y/y); Adjusted EBIT $134M (-56% y/y)earningsopen
Figures in the filing · each found in the filing text
| Sales revenue · Q4-2025 | $1.97B | -12% y/y |
| EBIT · Q4-2025 | $64M | -82% y/y |
| Adjusted EBIT · Q4-2025 | $134M | -56% y/y |
| Earnings per diluted share · Q4-2025 | $0.92 | -67% y/y |
| Adjusted earnings per diluted share · Q4-2025 | $0.75 | -60% y/y |
| Net cash provided by operating activities · Q4-2025 | $502M | -7% y/y |
| Full year sales revenue · FY2025 | $8.75B | -7% y/y |
| Full year adjusted EBIT · FY2025 | $930M | -28% y/y |
| Full year operating cash flow · FY2025 | $970M | -25% y/y |
Risks flagged
Broad-based demand weakness across all segments; inventory destocking and competitive pressure.
“Sales revenue down 12% YoY; volume/mix down 11%; weakness in consumer discretionary, building and construction, export markets; acetate tow destocking.”
Chemical Intermediates segment facing increased competitive pressure from Asia.
“Lower selling prices in Chemical Intermediates due to increased competitive pressure from Asia.”
4 Nov 202510-QEastman reported Q3 2025 results with significant declines: sales -11%, EBIT -43%, and net income -74% YoY, driven by weak demand and cost inflation.open
Figures in the filing · each found in the filing text
| Sales · Q3-2025 | $2.20B | -11% y/y |
| Net Earnings Attributable to Eastman · Q3-2025 | $47M | -74% y/y |
| Earnings Before Interest and Taxes (EBIT) · Q3-2025 | $188M | -43% y/y |
| Adjusted EBIT (excl. non-core) · Q3-2025 | $210M | -43% y/y |
| Gross Profit · Q3-2025 | $433M | -28% y/y |
| Diluted EPS · Q3-2025 | $0.40 | -74% y/y |
| Adjusted Diluted EPS · Q3-2025 | $1.14 | -50% y/y |
| Operating Cash Flow · 9M-2025 | $468M | -37% y/y |
| Sales Volume/Mix Effect · Q3-2025 | $-248M | -10% y/y |
| Price Effect · Q3-2025 | $-34M | -1% y/y |
Risks flagged
End Market Weakness
“Sales revenue decreased in third quarter 2025 compared to third quarter 2024 due to lower sales volume primarily driven by continued weakness across key end markets.” · word for word
Raw Material and Energy Cost Inflation
“EBIT excluding non-core items decreased ... due to lower sales volume, and lower selling prices and higher raw material and energy costs”
Tariff and Trade Disruption
“impacts from U.S. tariffs, reciprocal tariffs, and global trade disruption” · word for word
Restructuring Execution Risk
“Total $ 20 $ 30 $ 42 $ 41” · word for word
3 Nov 20258-K · 2.02Sales revenue $2.20B (-11% y/y); EBIT $188M (-43% y/y); Adjusted EBIT $210M (-43% y/y); Guidance: Expect greater than normal seasonal decline in Q4; cost reduction of >$75M in 2025 and ~$100M in 2026earningsopen
Figures in the filing · each found in the filing text
| Sales revenue · Q3-2025 | $2.20B | -11% y/y |
| EBIT · Q3-2025 | $188M | -43% y/y |
| Adjusted EBIT · Q3-2025 | $210M | -43% y/y |
| Earnings per diluted share · Q3-2025 | $0.40 | -74% y/y |
| Adjusted earnings per diluted share · Q3-2025 | $1.14 | -50% y/y |
| Net cash provided by operating activities · Q3-2025 | $402M | +2% y/y |
Guidance
Expect greater than normal seasonal decline in Q4; cost reduction of >$75M in 2025 and ~$100M in 2026
Management expects continued demand weakness in Q4 with consumer discretionary softness and inventory destocking; cost reduction actions underway but not enough to offset headwinds
Risks flagged
Continued demand weakness in consumer discretionary end markets
“Weakness in consumer discretionary end markets as well as customer unwinding of tariff-related inventory prepositioned in the first half of the year” · word for word
Tariff-related inventory destocking and trade dispute impact
“Customers unwinding inventory that was prepositioned to avoid tariff risk in a weakening consumer environment” · word for word
Competitive spread compression in Chemical Intermediates
“Chemical Intermediates saw competitive spread compression” · word for word
Eastman Chemical Company — questions
- What did Eastman Chemical Company file recently?
- 11 SEC filings in the last 12 months. Latest: 8-K on 2026-10-20 — Eastman Chemical amended its bylaws to align with Delaware law, update procedural mechanics for stockholder meetings and nominations, and make ministerial changes. No material financial or operational impact.
Every figure on this page comes from Eastman Chemical Company's own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.